Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2019 | |||||||||
|
acyl-CoA dehydrogenase family member 8 | 0.506 | 0.885 | 5.6E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1998 | 2018 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 13 | 0.496 | 0.769 | 5.1E-15 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
adenylate kinase 3 | 0.691 | 0.462 | 1.1E-04 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2003 | 2010 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2018 | ||||||||
|
annexin A2 | 0.453 | 0.808 | 9.8E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
annexin A5 | 0.458 | 0.769 | 3.8E-15 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2012 | 2018 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 4 | 1997 | 2018 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2018 | ||||||||
|
apolipoprotein H | 0.563 | 0.769 | 1.6E-15 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2014 | 2018 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator like | 0.510 | 0.885 | 0.99 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
asparaginase and isoaspartyl peptidase 1 | 0.494 | 0.808 | 2.8E-05 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2020 | ||||||||
|
ataxin 3 | 0.521 | 0.808 | 0.11 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1994 | 2001 | ||||||||
|
biogenesis of lysosomal organelles complex 1 subunit 2 | 0.760 | 0.346 | 1.2E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
complement C1q binding protein | 0.569 | 0.692 | 2.0E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2018 |